Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-κB-Mediated Inflammation
Andro treatment inhibits diabetes-induced cardiac hypertrophy. (a and b) WGA staining showing the cross-sectional area of cardiomyocytes. (c) The ratio of heart weight/tibial length (HW/TL). (d and e) mRNA levels of ANP and BNP in the diabetic myocardium. (f and g) mRNA levels of ANP and BNP in high glucose-stimulated H9c2 cardiomyoblasts. compared to control or NG; compared to DM or HG.